NCT03337529View on ClinicalTrials.gov

Restless Legs Syndrome in Hemodialysis Patients

NACompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

September 15, 2017

Primary Completion Date

April 15, 2018

Study Completion Date

April 15, 2018

Conditions
Restless Leg Syndrome
Interventions
OTHER

Vitamin C

200 mg Vitamin C will be given on daily basis for 8 weeks

OTHER

Placebo

200 mg placebo will be given on daily basis for 8 weeks

Trial Locations (1)

Unknown

Makassed General Hospital, Beirut

All Listed Sponsors
lead

Makassed General Hospital

OTHER

NCT03337529 - Restless Legs Syndrome in Hemodialysis Patients | Biotech Hunter | Biotech Hunter